Research

Clinical Research

If you would like to participate in any of the actively recruiting trials visit *Participate in a Research Study*. Volunteering for clinical trials may someday benefit you or someone you know since you will be contributing to the development of the new and innovative treatments being investigated at the Alberta Diabetes Institute.

Upcoming Clinical Trials

  • Biomedical
    Investigator / Sponsor
    Disease Phase Trial Type
    Tammy McNab / Novo Nordisk
    Pregnant Women with type 1 Diabetes
    3 Efficacy and Safety of a Basal Insulin
    Andrea Haqq / GLWL
    Prader Willi Syndrome
    2 Efficacy and safety of a new medication for treating feelings of hunger
  • Nutrition
    Investigator / Sponsor
    Disease Phase Trial Type
    Dr. Jens Walter
     

  • Physical Activity
    Investigator / Sponsor
    Disease Phase Trial Type
    Normand Boulé
    Type 2 Diabetes
    N/A
    Aerobic Exercise

Recruiting Clinical Trials

  • Biomedical
    Investigator / Sponsor
    Disease Phase Trial Type
    Peter Senior / Novo Nordisk
    Type 2 Diabetes
    3 Efficacy and safety of faster-acting insulin aspart
    Peter Senior / ProMetic
    Type 2 Diabetes with metabolic syndrome
    2 Efficacy and safety of the drug PBI-4050
    Andrea Haqq / OPKO
    Growth hormone deficiency in children
    3 Efficacy and safety of a longer-acting growth hormone
  • Nutrition
    Investigator / Sponsor
    Disease Phase Trial Type
    Rene Jacobs
    Cardiovascular Disease
    Observational Examining the role of different dietary sources of choline on postprandial choline and trimethylamine N-oxide (TMAO) metabolism
    Donna Vine

    Polycystic Ovary Syndrome

    Intervention

    Polycystic Ovary Syndrome Clinical Trial

    Diana Mager
    Diabetic Nephropathy
    Intervention Vitamin D supplementation and bone health in adults with diabetic neuropathy: a 2 year follow up study
    Diana Mager Celiac Disease Observational Quality of Life and Dietary Adherence to the Gluten Free Diet in Children with Celiac Disease
    Diana Mager Celiac Disease
    Observational Adherence to Vitamin Supplementation in Celiac Disease
    Diana Mager Non-Alcoholic Fatty Liver Disease
    Intervention Dietary Fructose as a Mediator to Altered hepatic Energy Metabolism
    Diana Mager Non-Alcoholic Fatty Liver Disease Intervention Altered Fat Metabolism as a Mediator to Non Alcoholic Fatty Liver Disease (NAFLD)
    Diana Mager End Stage Liver Disease Awaiting Transplantation (Infants)
    Intervention Effects of Branched Chain Amino Acid (BCAA) Supplementation on Growth and Neurodevelopment
    Andrea Haqq
    Pediatric Prader-Willi Syndrome and Healthy Controls Observational
     Nervous system function in children and teens
    Jens Walter
    Healthy Overweight Men and Women
    Intervention The Alberta FYBER Study (Feed Your Gut Bacteria More Fiber)
    Carla Prado
    Advanced colorectal cancer patients Intervention
    Protein Recommendations to Increase Muscle (PRIME)
    Vera Mazurak Lung Cancer
    Observational Eating Strategies for Chemotherapy Treatment
    Carla Prado Newly diagnosed, treatment naive cancer patients with solid tumors Observational
    Resting Energy Expenditure in Cancer: Associations with Body Composition, Dietary Intake, and Exercise Habits (RECODE)
  • Physical Activity
    Investigator / Sponsor
    Disease Phase Trial Type
    Jane Yardley
    Type 1 Diabetes
    Observation Effects of physical fitness on glycemic responses to high intensity exercise
    Jane Yardley
    Type 1 Diabetes
    Observation Blood Glucose Responses to Resistance Exercise in Type 1 Diabetes
    Jane Yardley
    Healthy Participants matching islet transplant participants
    Observation The Impact of Exercise on Blood Glucose in Islet Transplant Recipients
    Margie Davenport
    Postpartum Women
    Observational N/A
    Margie Davenport
    Pregnant Women
    Observational

    N/A

    Margie Davenport
    Pregnant Women
    Observational N/A
    Normand Boulé
    Jordan Rees
    Type 2 Diabetes
    Observation Exercise-Physical Activity Diabetes Glucose Monitoring (E-PAraDiGM) Protocol

Ongoing Clinical Trials (Not Recruiting)

  • Biomedical
    Investigator / Sponsor
    Disease Phase Trial Type
    Peter Senior / Joslin Diabetes Institute
    Type 1 Diabetes with Kidney Disease
    3 Drug
    Peter Senior / Bristol-Myers Squibb
    Type 1 Diabetes
    3 Efficacy and safety of the drug Dapagliflozin
    Dr. Alicia Chan / Replagal
    Fabry Disease
    N/A Drug
    Dr. Alicia Chan / CFDI Data Registry
    Fabry Disease
    N/A Registry
    Peter Senior / Novo Nordisk
    Newly Diagnosed Type 1 Diabetes
    2 Effect of a combination of two drugs (NNC0114-006 and liraglutide) on preservation of beta cell function
    Peter Senior / Sanofi
    Type 1 Diabetes
    4 Efficacy of a longer-acting basal insulin
  • Nutrition
    Investigator / Sponsor
    Disease Phase Trial Type
    Dr. Diana Mager
    Diabetic Nepropathy
    Intervention
    Dr. Carla Prado
    Postpartum Women
    Observation
    Dr. Rhonda Bell
    Pregnant Women
    Intervention
    Dr. Cathy Chan
    Healthy Adults
    Intevention
  • Physical Activity
    Investigator / Sponsor
    Disease Phase Trial Type
    Jane Yardley

    The Impact of Exercise on Blood Glucose in Islet Transplant Recipients

Completed Clinical Trials

  • Biomedical
    Investigator / Sponsor
    Disease Phase Trial Type
    Dr. Peter Senior / ProMetic
    Type 2 Diabetes with Metabolic Syndrome
    2 Drug
    Dr. Peter Senior / Novo Nordisk
    Type 1 Diabetes
    3b Efficacy and safety of a faster-acting insulin when used in an insulin pump
    Dr. Peter Senior / Servier
    Type 2 Diabetes with Kidney Disease
    2 Drug
    Dr. Raj Padwal / Novo Nordisk
    Type 2 Diabetes
    3a Drug
    Dr. Mary Jetha
    Dr. Andrea Haqq / Merck
    Type 2 Diabetes
    3 Drug
    Dr. Peter Senior / Novo Nordisk
    Type 1 Diabetes
    3a Drug
    Dr. Peter Senior / Novo Nordisk
    Type 1 Diabetes
    3a Drug
    Dr. Peter Senior / AstraZeneca
    Type 2 Diabetes with Cardiovascular Disease
    3 Drug
    Dr. Raj Padwal / Novo Nordisk Obesity 3 Drug
    Dr. Raj Padwal / Valencia
    Refractory Hypertension
    N/A Device
  • Physical Activity
    Investigator / Sponsor
    Disease Phase Trial Type